WTP for a QALY and health states: More money for severer health states?

Por Shiroiwa, Takeru, Igarashi, Ataru, Fukuda, Takashi, Ikeda, Shunya
Publicado em 2013

Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records

Por Akiyama, Naomi, Shiroiwa, Takeru, Fukuda, Takashi, Murashima, Sachiyo, Hayashida, Kenshi
Publicado no PLoS One (2018)

Identification of Renieramycin A as an Antileishmanial Substance in a Marine Sponge Neopetrosia sp.

Por Nakao, Yoichi, Shiroiwa, Takeru, Murayama, Shuhei, Matsunaga, Shigeki, Goto, Yasuyuki, Matsumoto, Yoshitsugu, Fusetani, Nobuhiro
Publicado em 2004

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D

Por Shiroiwa, Takeru, Fukuda, Takashi, Ikeda, Shunya, Igarashi, Ataru, Noto, Shinichi, Saito, Shinya, Shimozuma, Kojiro
Publicado no Qual Life Res (2015)

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC...

Por Hagiwara, Yasuhiro, Shiroiwa, Takeru, Shimozuma, Kojiro, Kawahara, Takuya, Uemura, Yukari, Watanabe, Takanori, Taira, Naruto, Fukuda, Takashi, Ohashi, Yasuo, Mukai, Hirofumi
Publicado no Pharmacoeconomics (2017)

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

Por Shiroiwa, Takeru, Fukuda, Takashi, Shimozuma, Kojiro, Mouri, Mitsuko, Hagiwara, Yasuhiro, Kawahara, Takuya, Ohsumi, Shozo, Hozumi, Yasuo, Sagara, Yoshiaki, Ohashi, Yasuo, Mukai, Hirofumi
Publicado no BMC Cancer (2017)